Familial amyotrophic lateral sclerosis (FALS) ALS Superoxide dismutase type 1 (SOD1) Motor neuron Neurodegeneration Microglia Mutant superoxide dismutase type 1 (MTSOD1), the most common known cause of familial amyotrophic lateral sclerosis (FALS), is believed to cause FALS as a result of a toxicity of the protein. MTSOD1s with full dismutase enzymatic activity (e.g., G37R) and without any enzymatic activity (e.g., G85R) cause FALS, demonstrating that the ability of MTSOD1 to cause FALS is not dependent on the dismutase activity; however, it remains unclear whether MTSOD1 dismutase activity can influence disease phenotype. In the present study, we selectively knocked down G85R expression in particular cell types of G85R mice. Results following knockdown of G85R in motor neurons (MNs)/interneurons of G85R mice were similar to results from a published study involving knockdown of G37R in G37R mice; however, G85R knockdown in microglia/ macrophages induced a prolonged early and late disease phase while G37R knockdown in the same cells only affected late phase. These results show that: (i) MN as well as non-MN expression of G85R, like G37R, has a significant effect on disease in transgenic mice -indicating the role of non-cell autonomous degeneration in both dismutase-active and inactive MTSOD1s. (ii) The effect of MTSOD1 expression in microglia/ macrophages varies with different mutants, and may be influenced by the MTSOD1's dismutase activity.
Introduction
Amyotrophic lateral sclerosis (ALS) is a relentless motor system degeneration that results in death usually 3-5 years after the onset. Approximately 10% of cases are inherited, and 15% of these familial ALS (FALS) cases are caused by mutations of Cu/Zn superoxide dismutase type 1 (SOD1). Scientists have vigorously investigated mutant (MT) SOD1-induced FALS under the assumption that this disease involves pathways of motor neuron (MN) death that are similar to those operative in sporadic ALS.
MTSOD1 is believed to cause cell death by means of a toxic gain of function rather than a loss of function. The mechanism by which MTSOD1 exerts its toxicity, however, remains unclear. MTSOD1s with full dismutase enzymatic activity (e.g., G37R) and without any enzymatic activity (e.g., G85R) cause FALS (Borchelt et al., 1994) , demonstrating that the ability of the mutant protein to cause FALS is not dependent on its dismutase activity. Despite evidence indicating that a gain of function of MTSOD1 leads to FALS, the presence or absence of dismutase activity of the MT enzyme may still affect the pathogenesis or phenotype of the disease.
One important issue related to ALS is whether MN death is non-cell autonomous, i.e., whether MN death is influenced by the production of pathogenic factors produced in other cell types besides MNs. Compelling data related to this topic and especially relevant to the present study came from the use of CreLoxP technology to decrease the expression of MTSOD1 in one neural cell type with a constant MTSOD1 expression in the remainder of cell types (Boillee et al., 2006a; Yamanaka et al., 2008) . In these experiments, mice were generated that carried a Cre recombinase transgene (that can excise a "floxed" gene that is flanked by LoxP sites) under the control of a cell type-specific transcriptional control element along with a floxed G37R MTSOD1 (G37R flox ) transgene. These mice were crossed with a mouse carrying Cre expressed in MNs (under the Islet-1 or VAChT promoter) or microglia/macrophages (under the CD11b promoter) to determine the effect of disease following a knockdown in G37R expression in these cell types. A decrease in G37R expression in the G37R flox mice in MNs and other neurons delayed the onset and early phase of disease, while a decrease in expression of G37R in microglia and activated macrophages had little effect on the onset or early phase of disease, but significantly increased disease duration because of slowing of the late phase of disease.
In the present study, we carried out investigations of non-cell autonomous degeneration in G85R flox mice similar to those carried out with G37R flox mice (Boillee et al., 2006a; Yamanaka et al., 2008) .
Since G85R has no dismutase activity, while G37R has full dismutase activity, we reasoned that a comparison of our results with those obtained with G37R flox transgenic mice might clarify the importance of the mutant's enzymatic activity in different neural cell types in FALS 
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